Ketamine Queen CAGED — Hollywood’s Deadly Dealer Falls

A judge holding a gavel above a wooden block

The “Ketamine Queen” who peddled deadly drugs to Hollywood elites, even after knowing her supply killed before, finally faces 15 years behind bars for Matthew Perry’s overdose death.

Story Snapshot

Jasveen Sangha sentenced to 15 years in federal prison plus three years supervised release for distributing ketamine that killed Matthew Perry.
Sangha sold 25 vials of ketamine to Perry’s assistant just days before the actor’s death on October 28, 2023.
Prosecutors highlighted Sangha’s lack of remorse, as she continued dealing drugs despite prior deaths linked to her supply.
Third of five defendants sentenced; two middlemen face up to 25 years in coming weeks.

Sangha’s Drug Network Exposed

Jasveen Sangha, dubbed the “Ketamine Queen,” built a distribution operation targeting wealthy Los Angeles clientele, including Hollywood stars. Federal prosecutors detailed how she sold 25 vials of ketamine for $6,000 to Perry’s personal assistant Kenneth Iwamasa on October 24, 2023. Perry died four days later in his Pacific Palisades hot tub from the overdose. Sangha’s network involved middlemen like Iwamasa and Erik Fleming, who facilitated deals. This case reveals how elite enablers prey on addiction without accountability, eroding personal responsibility in affluent circles.

Persistent Criminal Pattern Despite Warnings

Sangha’s operation linked to at least two prior deaths, including Cody McLaury in 2019, yet she pressed on with sales undeterred. Prosecutors stressed this pattern of behavior showed no remorse, even after learning her ketamine caused fatalities. She marketed herself exclusively to the rich and famous, operating a sophisticated supply chain. Federal indictment came in August 2024, followed by her guilty plea to five charges on August 3, 2025. Such callousness underscores failures in holding powerful networks accountable, a concern shared across political lines frustrated with elite impunity.

Sentencing Delivers Long-Awaited Justice

Federal Judge Sherilyn Peace Garnett imposed the full 15-year sentence in April 2026, rejecting defense pleas for time served based on Sangha’s inmate behavior. The judge urged Sangha to show “epic resilience” in prison. Prosecutors had recommended the maximum, citing her ongoing dealings post-deaths. Perry’s family delivered impact statements, emphasizing the devastation. This outcome affirms federal commitment to prosecuting suppliers in overdose cases, offering closure while signaling tougher enforcement against drug traffickers.

As the third of five defendants, Sangha’s case advances toward full resolution. Kenneth Iwamasa faces up to 15 years on April 22, 2026; Erik Fleming up to 25 years on April 29. These proceedings highlight vulnerabilities in controlled substance access and may spur stricter ketamine regulations.

Broader Implications for Hollywood and Beyond

The Perry investigation sets precedent for dismantling celebrity-targeted drug rings, affecting entertainment industry awareness of substance abuse. It exposes how unchecked distribution thrives amid wealth and fame, fueling public distrust in systems that shield elites. Both conservatives decrying moral decay and liberals wary of inequality see this as evidence of government prioritizing the powerful over everyday accountability. Heightened scrutiny could drive policy shifts on drug access, reinforcing law and order principles central to American justice.